var data = {
 'Enrichment results': {
 'Biological Process': {
' regulation of innate immune response ': ' 65 ',
' positive regulation of cytokine production ': ' 61 ',
' leukocyte cell-cell adhesion ': ' 67 ',
' positive regulation of defense response ': ' 63 ',
' response to interferon-gamma ': ' 38 ',
' response to lipopolysaccharide ': ' 53 ',
' positive regulation of innate immune response ': ' 54 ',
' response to molecule of bacterial origin ': ' 53 ',
' activation of innate immune response ': ' 49 ',
' leukocyte aggregation ': ' 62 ',
' innate immune response-activating signal transduction ': ' 48 ',
' T cell activation ': ' 60 ',
' T cell aggregation ': ' 60 ',
' lymphocyte aggregation ': ' 60 ',
' cellular response to interferon-gamma ': ' 33 ',
' pattern recognition receptor signaling pathway ': ' 38 ',
' response to tumor necrosis factor ': ' 45 ',
' regulation of cell-cell adhesion ': ' 53 ',
' regulation of immune effector process ': ' 55 ',
' toll-like receptor signaling pathway ': ' 33 ',
' response to type I interferon ': ' 25 ',
' positive regulation of response to external stimulus ': ' 45 ',
' cellular response to tumor necrosis factor ': ' 42 ',
' regulation of chemotaxis ': ' 35 ',
' type I interferon signaling pathway ': ' 24 ',
' cellular response to type I interferon ': ' 24 ',
' regulation of cell activation ': ' 59 ',
' positive regulation of cell adhesion ': ' 51 ',
' leukocyte migration ': ' 49 ',
' response to virus ': ' 53 ',
' positive regulation of cellular component movement ': ' 53 ',
' positive regulation of cell-cell adhesion ': ' 40 ',
' I-kappaB kinase/NF-kappaB signaling ': ' 41 ',
' positive regulation of leukocyte migration ': ' 27 ',
' positive regulation of locomotion ': ' 53 ',
' positive regulation of chemotaxis ': ' 28 ',
' defense response to virus ': ' 46 ',
' positive regulation of cell motility ': ' 51 ',
' positive regulation of cell migration ': ' 50 ',
' regulation of leukocyte cell-cell adhesion ': ' 43 ',
' regulation of leukocyte migration ': ' 30 ',
' regulation of leukocyte activation ': ' 54 ',
' interferon-gamma-mediated signaling pathway ': ' 23 ',
' regulation of leukocyte chemotaxis ': ' 24 ',
' immune response-activating signal transduction ': ' 56 ',
' positive regulation of immune effector process ': ' 30 ',
' positive regulation of leukocyte cell-cell adhesion ': ' 35 ',
' regulation of homotypic cell-cell adhesion ': ' 43 ',
' positive regulation of leukocyte chemotaxis ': ' 22 ',
' positive regulation of behavior ': ' 29 ',
' cytokine secretion ': ' 31 ',
' positive regulation of leukocyte activation ': ' 42 ',
' positive regulation of homotypic cell-cell adhesion ': ' 34 ',
' toll-like receptor 3 signaling pathway ': ' 23 ',
' positive regulation of cell activation ': ' 42 ',
' toll-like receptor 4 signaling pathway ': ' 25 ',
' regulation of I-kappaB kinase/NF-kappaB signaling ': ' 35 ',
' cell chemotaxis ': ' 35 ',
' regulation of behavior ': ' 36 ',
' regulation of lymphocyte activation ': ' 47 ',
' regulation of T cell activation ': ' 39 ',
' positive regulation of T cell activation ': ' 32 ',
' regulation of sequence-specific DNA binding transcription factor activity ': ' 44 ',
' regulation of cytokine secretion ': ' 27 ',
' cellular response to molecule of bacterial origin ': ' 28 ',
' negative regulation of cytokine production ': ' 33 ',
' leukocyte differentiation ': ' 50 ',
' regulation of response to wounding ': ' 46 ',
' cellular response to lipopolysaccharide ': ' 27 ',
' regulation of type I interferon production ': ' 24 ',
' cellular response to biotic stimulus ': ' 29 ',
' positive regulation of lymphocyte activation ': ' 37 ',
' MyD88-independent toll-like receptor signaling pathway ': ' 20 ',
' leukocyte chemotaxis ': ' 29 ',
' positive regulation of production of molecular mediator of immune response ': ' 18 ',
' type I interferon production ': ' 24 ',
' leukocyte proliferation ': ' 36 ',
' regulation of leukocyte mediated immunity ': ' 26 ',
' angiogenesis ': ' 46 ',
' regulation of apoptotic signaling pathway ': ' 43 ',
' tumor necrosis factor-mediated signaling pathway ': ' 27 ',
' regulation of production of molecular mediator of immune response ': ' 21 ',
' mononuclear cell proliferation ': ' 34 ',
' interleukin-1 beta production ': ' 16 ',
' interleukin-1 production ': ' 17 ',
' positive regulation of leukocyte proliferation ': ' 23 ',
' regulation of inflammatory response ': ' 35 ',
' regulation of leukocyte proliferation ': ' 29 ',
' negative regulation of immune system process ': ' 41 ',
' adaptive immune response ': ' 41 ',
' myeloid leukocyte activation ': ' 25 ',
' regulation of mononuclear cell proliferation ': ' 28 ',
' T cell differentiation ': ' 29 ',
' positive regulation of mononuclear cell proliferation ': ' 22 ',
' regulation of protein secretion ': ' 42 ',
' leukocyte mediated immunity ': ' 36 ',
' T cell proliferation ': ' 26 ',
' adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains ': ' 31 ',
' lymphocyte proliferation ': ' 32 ',
' protein secretion ': ' 47 ',
' regulation of toll-like receptor signaling pathway ': ' 13 ',
' cell activation involved in immune response ': ' 28 ',
' cytokine metabolic process ': ' 20 ',
' alpha-beta T cell activation ': ' 20 ',
' interleukin-12 production ': ' 14 ',
' toll-like receptor 2 signaling pathway ': ' 17 ',
' cytoplasmic pattern recognition receptor signaling pathway ': ' 14 ',
' interleukin-10 production ': ' 13 ',
' positive regulation of I-kappaB kinase/NF-kappaB signaling ': ' 25 ',
' regulation of transcription factor import into nucleus ': ' 18 ',
' positive regulation of cytokine production involved in immune response ': ' 11 ',
' positive regulation of establishment of protein localization ': ' 46 ',
' negative regulation of sequence-specific DNA binding transcription factor activity ': ' 22 ',
' leukocyte activation involved in immune response ': ' 27 ',
' positive regulation of cytokine secretion ': ' 18 ',
' positive regulation of peptidase activity ': ' 23 ',
' lymphocyte differentiation ': ' 34 ',
' MyD88-dependent toll-like receptor signaling pathway ': ' 17 ',
' positive regulation of type I interferon production ': ' 17 ',
' regulation of multi-organism process ': ' 45 ',
' regulation of lymphocyte proliferation ': ' 26 ',
' myeloid leukocyte migration ': ' 23 ',
' transcription factor import into nucleus ': ' 18 ',
' regulation of granulocyte chemotaxis ': ' 12 ',
' positive regulation of proteolysis ': ' 37 ',
' positive regulation of endopeptidase activity ': ' 22 ',
' regulation of adaptive immune response ': ' 20 ',
' positive regulation of epithelial cell proliferation ': ' 23 ',
' cytokine biosynthetic process ': ' 19 ',
' epithelial cell proliferation ': ' 36 ',
' regulation of epithelial cell proliferation ': ' 32 ',
' production of molecular mediator of immune response ': ' 23 ',
' antigen processing and presentation of exogenous peptide antigen via MHC class I ': ' 16 ',
' regulation of T cell differentiation ': ' 19 ',
' positive regulation of lymphocyte proliferation ': ' 20 ',
' chemokine-mediated signaling pathway ': ' 16 ',
' regulation of interleukin-6 production ': ' 18 ',
' negative regulation of cell activation ': ' 23 ',
' interleukin-1 beta secretion ': ' 11 ',
' regulation of interleukin-12 production ': ' 13 ',
' regulation of interferon-beta production ': ' 12 ',
' cellular response to virus ': ' 11 ',
' antigen processing and presentation of endogenous antigen ': ' 8 ',
' regulation of ERK1 and ERK2 cascade ': ' 28 ',
' alpha-beta T cell differentiation ': ' 16 ',
' regulation of leukocyte differentiation ': ' 28 ',
' positive regulation of sequence-specific DNA binding transcription factor activity ': ' 27 ',
' response to interleukin-1 ': ' 19 ',
' antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent ': ' 15 ',
' interferon-gamma production ': ' 18 ',
' interleukin-6 production ': ' 18 ',
' gland morphogenesis ': ' 20 ',
' positive regulation of cysteine-type endopeptidase activity ': ' 20 ',
' regulation of response to cytokine stimulus ': ' 21 ',
' positive regulation of leukocyte mediated immunity ': ' 16 ',
' interferon-beta production ': ' 12 ',
' negative regulation of immune response ': ' 19 ',
' regulation of cytokine biosynthetic process ': ' 17 ',
' positive regulation of cysteine-type endopeptidase activity involved in apoptotic process ': ' 19 ',
' activation of protein kinase activity ': ' 42 ',
' cell-type specific apoptotic process ': ' 41 ',
' regulation of interleukin-1 beta production ': ' 12 ',
' regulation of NF-kappaB import into nucleus ': ' 12 ',
' NF-kappaB import into nucleus ': ' 12 ',
' regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains ': ' 18 ',
' regulation of cysteine-type endopeptidase activity ': ' 26 ',
' regulation of T cell proliferation ': ' 21 ',
' interleukin-1 secretion ': ' 11 ',
' toll-like receptor 9 signaling pathway ': ' 15 ',
' regulation of cytokine production involved in immune response ': ' 13 ',
' regulation of interleukin-1 production ': ' 13 ',
' negative regulation of viral genome replication ': ' 12 ',
' extrinsic apoptotic signaling pathway ': ' 27 ',
' regulation of protein import into nucleus ': ' 23 ',
' granulocyte chemotaxis ': ' 17 ',
' ERK1 and ERK2 cascade ': ' 28 ',
' tube morphogenesis ': ' 36 ',
' positive regulation of inflammatory response ': ' 18 ',
' regulation of cytokine-mediated signaling pathway ': ' 20 ',
' positive regulation of protein transport ': ' 40 ',
' toll-like receptor 5 signaling pathway ': ' 14 ',
' positive regulation of protein secretion ': ' 25 ',
' positive regulation of T cell proliferation ': ' 16 ',
' regulation of protein import ': ' 23 ',
' cytokine production involved in immune response ': ' 14 ',
' positive regulation of cytokine biosynthetic process ': ' 13 ',
' regulation of leukocyte apoptotic process ': ' 15 ',
' antigen processing and presentation of peptide antigen via MHC class I ': ' 17 ',
' peptidyl-tyrosine modification ': ' 33 ',
' chemokine production ': ' 14 ',
' protein import into nucleus ': ' 29 ',
' protein targeting to nucleus ': ' 29 ',
' single-organism nuclear import ': ' 29 ',
' renal system development ': ' 30 ',
' regulation of reactive oxygen species metabolic process ': ' 21 ',
' regulation of organ morphogenesis ': ' 23 ',
' regulation of hemopoiesis ': ' 32 ',
' negative regulation of cytokine secretion ': ' 11 ',
' regulation of nucleocytoplasmic transport ': ' 25 ',
' viral genome replication ': ' 16 ',
' nuclear import ': ' 29 ',
' antigen processing and presentation of endogenous peptide antigen ': ' 7 ',
' regulation of peptidyl-tyrosine phosphorylation ': ' 25 ',
' reactive oxygen species metabolic process ': ' 27 ',
' regulation of chemokine production ': ' 13 ',
' regulation of cysteine-type endopeptidase activity involved in apoptotic process ': ' 24 ',
' positive regulation of response to wounding ': ' 21 ',
' negative regulation of viral life cycle ': ' 15 ',
' negative regulation of innate immune response ': ' 10 ',
' regulation of interleukin-1 beta secretion ': ' 9 ',
' toll-like receptor TLR1:TLR2 signaling pathway ': ' 14 ',
' toll-like receptor TLR6:TLR2 signaling pathway ': ' 14 ',
' granulocyte migration ': ' 17 ',
' T cell activation involved in immune response ': ' 15 ',
' peptidyl-tyrosine phosphorylation ': ' 32 ',
' positive regulation of interleukin-6 production ': ' 13 ',
' positive regulation of interferon-beta production ': ' 9 ',
' positive regulation of secretion by cell ': ' 32 ',
' negative regulation of viral process ': ' 15 ',
' regulation of coagulation ': ' 15 ',
' regulation of lymphocyte differentiation ': ' 19 ',
' positive regulation of chemokine production ': ' 11 ',
' negative regulation of multi-organism process ': ' 20 ',
' regulation of angiogenesis ': ' 24 ',
' T-helper 1 type immune response ': ' 10 ',
' CD4-positive, alpha-beta T cell differentiation ': ' 12 ',
' negative regulation of cell-cell adhesion ': ' 19 ',
' embryonic organ development ': ' 38 ',
' toll-like receptor 10 signaling pathway ': ' 13 ',
' regulation of extrinsic apoptotic signaling pathway ': ' 20 ',
' negative regulation of homotypic cell-cell adhesion ': ' 16 ',
' cellular response to interleukin-1 ': ' 15 ',
' regulation of canonical Wnt signaling pathway ': ' 26 ',
' regulation of endopeptidase activity ': ' 34 ',
' response to mechanical stimulus ': ' 24 ',
' negative regulation of T cell differentiation ': ' 9 ',
' regulation of interleukin-1 secretion ': ' 9 ',
' regulation of vasculature development ': ' 25 ',
' lipopolysaccharide-mediated signaling pathway ': ' 11 ',
' negative regulation of leukocyte activation ': ' 19 ',
' negative regulation of defense response ': ' 19 ',
' regulation of alpha-beta T cell activation ': ' 13 ',
' regulation of peptidase activity ': ' 35 ',
' canonical Wnt signaling pathway ': ' 29 ',
' urogenital system development ': ' 31 ',
' NIK/NF-kappaB signaling ': ' 16 ',
' intrinsic apoptotic signaling pathway ': ' 29 ',
' positive regulation of T cell differentiation ': ' 13 ',
' positive regulation of positive chemotaxis ': ' 8 ',
' negative regulation of protein transport ': ' 23 ',
' regulation of MAP kinase activity ': ' 39 ',
' regulation of leukocyte mediated cytotoxicity ': ' 11 ',
' positive regulation of secretion ': ' 33 ',
' positive regulation of lymphocyte differentiation ': ' 14 ',
' regulation of striated muscle cell differentiation ': ' 14 ',
' negative regulation of leukocyte cell-cell adhesion ': ' 15 ',
' epithelial tube morphogenesis ': ' 31 ',
' intracellular receptor signaling pathway ': ' 29 ',
' regulation of positive chemotaxis ': ' 8 ',
' positive regulation of protein import into nucleus ': ' 15 ',
' activation of cysteine-type endopeptidase activity ': ' 15 ',
' regulation of symbiosis, encompassing mutualism through parasitism ': ' 24 ',
' neutrophil chemotaxis ': ' 14 ',
' regulation of interleukin-10 production ': ' 10 ',
' cellular extravasation ': ' 10 ',
' negative regulation of lymphocyte activation ': ' 17 ',
' positive regulation of interleukin-12 production ': ' 9 ',
' nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway ': ' 11 ',
' negative regulation of response to external stimulus ': ' 27 ',
' regulation of viral genome replication ': ' 13 ',
' CD4-positive, alpha-beta T cell activation ': ' 12 ',
' regulation of protein localization to nucleus ': ' 23 ',
' leukocyte apoptotic process ': ' 15 ',
' positive regulation of protein import ': ' 15 ',
' negative regulation of intracellular signal transduction ': ' 37 ',
' negative regulation of type I interferon production ': ' 10 ',
' lymphocyte mediated immunity ': ' 25 ',
' positive regulation of interleukin-1 production ': ' 9 ',
' response to fluid shear stress ': ' 9 ',
' nucleotide-binding oligomerization domain containing signaling pathway ': ' 9 ',
' negative regulation of establishment of protein localization ': ' 23 ',
' response to dsRNA ': ' 13 ',
' regulation of odontogenesis ': ' 8 ',
' myeloid cell activation involved in immune response ': ' 12 ',
' nitric oxide biosynthetic process ': ' 12 ',
' positive regulation of apoptotic signaling pathway ': ' 21 ',
' protein localization to nucleus ': ' 31 ',
' negative regulation of leukocyte mediated cytotoxicity ': ' 6 ',
' antigen processing and presentation of endogenous peptide antigen via MHC class I ': ' 6 ',
' negative regulation of T cell activation ': ' 14 ',
' response to hypoxia ': ' 28 ',
' alpha-beta T cell activation involved in immune response ': ' 10 ',
' alpha-beta T cell differentiation involved in immune response ': ' 10 ',
' cytoplasmic pattern recognition receptor signaling pathway in response to virus ': ' 7 ',
' morphogenesis of an epithelium ': ' 39 ',
' positive regulation of peptidyl-tyrosine phosphorylation ': ' 19 ',
' regulation of defense response to virus ': ' 21 ',
' positive regulation of vasculature development ': ' 17 ',
' positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains ': ' 12 ',
' B cell activation ': ' 24 ',
' neutrophil migration ': ' 14 ',
' regulation of cell killing ': ' 11 ',
' lymphocyte activation involved in immune response ': ' 18 ',
' positive regulation of leukocyte differentiation ': ' 17 ',
' protein import ': ' 29 ',
' positive regulation of interleukin-1 beta production ': ' 8 ',
' regulation of neutrophil chemotaxis ': ' 8 ',
' positive regulation of angiogenesis ': ' 16 ',
' necrotic cell death ': ' 10 ',
' regulation of intrinsic apoptotic signaling pathway ': ' 18 ',
' response to oxygen levels ': ' 29 ',
' negative regulation of leukocyte differentiation ': ' 13 ',
' kidney development ': ' 26 ',
' response to decreased oxygen levels ': ' 28 ',
' positive regulation of transcription factor import into nucleus ': ' 10 ',
' negative regulation of cell adhesion ': ' 23 ',
' regulation of interleukin-8 production ': ' 11 ',
' regulation of interferon-gamma production ': ' 14 ',
' positive regulation of interleukin-1 beta secretion ': ' 7 ',
' positive regulation of cell development ': ' 37 ',
' positive regulation of alpha-beta T cell activation ': ' 10 ',
' negative regulation of cell killing ': ' 6 ',
' programmed necrotic cell death ': ' 9 ',
' positive regulation of Wnt signaling pathway ': ' 19 ',
' positive regulation of adaptive immune response ': ' 12 ',
' regulation of lymphocyte mediated immunity ': ' 15 ',
' gland development ': ' 36 ',
' regulation of interleukin-2 production ': ' 10 ',
' endothelial cell proliferation ': ' 15 ',
' positive regulation of interleukin-1 secretion ': ' 7 ',
' negative regulation of lymphocyte differentiation ': ' 9 ',
' dendritic cell differentiation ': ' 9 ',
' regulation of Wnt signaling pathway ': ' 28 ',
' positive regulation of nucleocytoplasmic transport ': ' 15 ',
' type 2 immune response ': ' 8 ',
' positive chemotaxis ': ' 10 ',
' mammary gland morphogenesis ': ' 10 ',
' regulation of response to biotic stimulus ': ' 23 ',
' positive regulation of reactive oxygen species metabolic process ': ' 13 ',
' mesenchymal cell development ': ' 19 ',
' T cell differentiation involved in immune response ': ' 10 ',
' macrophage activation ': ' 10 ',
' regulation of type 2 immune response ': ' 7 ',
' positive regulation of neutrophil chemotaxis ': ' 7 ',
' regulation of protein targeting ': ' 27 ',
' regulation of neutrophil migration ': ' 8 ',
' negative regulation of natural killer cell mediated immunity ': ' 5 ',
' negative regulation of natural killer cell mediated cytotoxicity ': ' 5 ',
' myeloid leukocyte differentiation ': ' 20 ',
' ameboidal-type cell migration ': ' 28 ',
' negative regulation of transport ': ' 36 ',
' negative regulation of response to wounding ': ' 18 ',
' negative regulation of leukocyte mediated immunity ': ' 9 ',
' negative regulation of hemopoiesis ': ' 16 ',
' lymphocyte homeostasis ': ' 11 ',
' T cell mediated immunity ': ' 12 ',
' protein processing ': ' 28 ',
' stem cell development ': ' 19 ',
' interleukin-8 production ': ' 11 ',
' necroptotic process ': ' 8 ',
' positive regulation of interleukin-8 production ': ' 9 ',
' regulation of nitric oxide biosynthetic process ': ' 10 ',
' transmembrane receptor protein serine/threonine kinase signaling pathway ': ' 29 ',
' positive regulation of endothelial cell proliferation ': ' 11 ',
' regulation of cytoplasmic transport ': ' 35 ',
' negative regulation of leukocyte apoptotic process ': ' 9 ',
' protein complex localization ': ' 14 ',
' negative regulation of protein secretion ': ' 14 ',
' T cell migration ': ' 8 ',
' tissue remodeling ': ' 17 ',
' positive regulation of hemopoiesis ': ' 18 ',
' cellular response to interleukin-4 ': ' 7 ',
' positive regulation of myeloid leukocyte cytokine production involved in immune response ': ' 5 ',
' regulation of interferon-alpha production ': ' 6 ',
' PERK-mediated unfolded protein response ': ' 6 ',
' interferon-gamma secretion ': ' 6 ',
' vascular endothelial growth factor receptor signaling pathway ': ' 26 ',
' response to exogenous dsRNA ': ' 9 ',
' negative regulation of apoptotic signaling pathway ': ' 20 ',
' positive regulation of lymphocyte mediated immunity ': ' 11 ',
' stress-activated MAPK cascade ': ' 24 ',
' positive regulation of protein localization to nucleus ': ' 15 ',
' regulation of endothelial cell proliferation ': ' 13 ',
' nitric oxide metabolic process ': ' 12 ',
' zymogen activation ': ' 15 ',
' monocyte chemotaxis ': ' 10 ',
' interleukin-2 production ': ' 10 ',
' alpha-beta T cell proliferation ': ' 7 ',
' positive regulation of granulocyte chemotaxis ': ' 7 ',
' regulation of alpha-beta T cell differentiation ': ' 9 ',
' mammary gland development ': ' 16 ',
' interferon-alpha production ': ' 6 ',
' immunoglobulin secretion ': ' 6 ',
' regulation of monocyte chemotaxis ': ' 6 ',
' mesenchymal cell differentiation ': ' 19 ',
' innate immune response activating cell surface receptor signaling pathway ': ' 15 ',
' endothelium development ': ' 14 ',
' positive regulation of type 2 immune response ': ' 5 ',
' type I interferon biosynthetic process ': ' 5 ',
' positive regulation of nitric-oxide synthase biosynthetic process ': ' 5 ',
' stress-activated protein kinase signaling cascade ': ' 25 ',
' positive regulation of neutrophil migration ': ' 7 ',
' positive regulation of leukocyte apoptotic process ': ' 7 ',
' positive regulation of ERK1 and ERK2 cascade ': ' 18 ',
' DNA damage response, signal transduction by p53 class mediator ': ' 14 ',
' antigen processing and presentation ': ' 22 ',
' myeloid cell differentiation ': ' 28 ',
' kidney epithelium development ': ' 16 ',
' leukocyte mediated cytotoxicity ': ' 12 ',
' regulation of blood coagulation ': ' 12 ',
' regulation of hemostasis ': ' 12 ',
' regulation of intracellular protein transport ': ' 30 ',
' maintenance of location ': ' 25 ',
' regulation of wound healing ': ' 15 ',
' regulation of T cell mediated immunity ': ' 9 ',
' regulation of tumor necrosis factor-mediated signaling pathway ': ' 9 ',
' regulation of tumor necrosis factor production ': ' 13 ',
' positive regulation of protein binding ': ' 11 ',
' reactive nitrogen species metabolic process ': ' 12 ',
' positive regulation of interferon-gamma production ': ' 10 ',
' negative regulation of immune effector process ': ' 13 ',
' tumor necrosis factor production ': ' 13 ',
' negative regulation of ERK1 and ERK2 cascade ': ' 9 ',
' protein maturation ': ' 28 ',
' regulation of tumor necrosis factor superfamily cytokine production ': ' 13 ',
' negative regulation of coagulation ': ' 9 ',
' ER-nucleus signaling pathway ': ' 8 ',
' positive regulation of T cell mediated immunity ': ' 7 ',
' regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway ': ' 7 ',
' reactive oxygen species biosynthetic process ': ' 12 ',
' lymphocyte migration ': ' 11 ',
' cellular response to oxidative stress ': ' 21 ',
' negative regulation of protein phosphorylation ': ' 30 ',
' negative regulation of phosphorylation ': ' 32 ',
' positive regulation of canonical Wnt signaling pathway ': ' 15 ',
' regulation of neural precursor cell proliferation ': ' 11 ',
' extracellular matrix organization ': ' 30 ',
' regulation of binding ': ' 24 ',
' response to interleukin-4 ': ' 7 ',
' extracellular structure organization ': ' 30 ',
' positive regulation of stress-activated protein kinase signaling cascade ': ' 15 ',
' tumor necrosis factor superfamily cytokine production ': ' 13 ',
' negative regulation of peptidyl-serine phosphorylation ': ' 6 ',
' cytokine secretion involved in immune response ': ' 5 ',
' positive regulation of monocyte chemotaxis ': ' 5 ',
' regulation of viral process ': ' 19 ',
' Ras protein signal transduction ': ' 34 ',
' positive regulation of cytokine-mediated signaling pathway ': ' 7 ',
' positive regulation of extrinsic apoptotic signaling pathway ': ' 9 ',
' regulation of muscle cell differentiation ': ' 16 ',
' regulation of protein binding ': ' 17 ',
' stimulatory C-type lectin receptor signaling pathway ': ' 14 ',
' Wnt signaling pathway ': ' 32 ',
' transforming growth factor beta receptor signaling pathway ': ' 19 ',
' chronic inflammatory response ': ' 6 ',
' regulation of alpha-beta T cell proliferation ': ' 6 ',
' regulation of viral life cycle ': ' 18 ',
' positive regulation of intracellular transport ': ' 28 ',
' positive regulation of tumor necrosis factor production ': ' 9 ',
' negative regulation of lymphocyte mediated immunity ': ' 7 ',
' positive regulation of epithelial to mesenchymal transition ': ' 7 ',
' positive regulation of response to cytokine stimulus ': ' 7 ',
' leukocyte homeostasis ': ' 11 ',
' negative regulation of interleukin-10 production ': ' 5 ',
' positive regulation of interferon-alpha production ': ' 5 ',
' regulation of immunoglobulin secretion ': ' 5 ',
' tyrosine phosphorylation of STAT protein ': ' 10 ',
' regulation of reactive oxygen species biosynthetic process ': ' 10 ',
' positive regulation of protein serine/threonine kinase activity ': ' 24 ',
' intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress ': ' 9 ',
' regulation of transmembrane receptor protein serine/threonine kinase signaling pathway ': ' 20 ',
' cell killing ': ' 13 ',
' positive regulation of cellular protein localization ': ' 27 ',
' negative regulation of protein modification by small protein conjugation or removal ': ' 16 ',
' antigen processing and presentation of exogenous peptide antigen ': ' 17 ',
' negative regulation of alpha-beta T cell activation ': ' 6 ',
' positive regulation of leukocyte mediated cytotoxicity ': ' 7 ',
' protein oligomerization ': ' 33 ',
' cell differentiation involved in kidney development ': ' 8 ',
' regulation of protein ubiquitination ': ' 23 ',
' positive regulation of tumor necrosis factor superfamily cytokine production ': ' 9 ',
' heart morphogenesis ': ' 20 ',
' regulation of protein modification by small protein conjugation or removal ': ' 24 ',
' maintenance of location in cell ': ' 12 ',
' negative regulation of interleukin-12 production ': ' 5 ',
' angiogenesis involved in wound healing ': ' 5 ',
' positive regulation of T cell apoptotic process ': ' 5 ',
' regulation of immunoglobulin production ': ' 8 ',
' regulation of myeloid leukocyte mediated immunity ': ' 7 ',
' regulation of leukocyte degranulation ': ' 7 ',
' nucleocytoplasmic transport ': ' 31 ',
' signal transduction in response to DNA damage ': ' 14 ',
' glycosaminoglycan biosynthetic process ': ' 13 ',
' mammary gland epithelium development ': ' 10 ',
' antigen processing and presentation of peptide antigen ': ' 18 ',
' negative regulation of MAPK cascade ': ' 15 ',
' cellular response to transforming growth factor beta stimulus ': ' 21 ',
' maintenance of protein location in cell ': ' 11 ',
' regulation of mitotic cell cycle ': ' 34 ',
' aminoglycan biosynthetic process ': ' 13 ',
' positive regulation of endocytosis ': ' 13 ',
' positive regulation of phagocytosis ': ' 8 ',
' multi-multicellular organism process ': ' 21 ',
' negative regulation of protein ubiquitination ': ' 15 ',
' positive regulation of cell cycle ': ' 26 ',
' fat cell differentiation ': ' 18 ',
' regulation of muscle system process ': ' 18 ',
' nuclear transport ': ' 31 ',
' muscle organ development ': ' 27 ',
' response to transforming growth factor beta ': ' 21 ',
' lipid storage ': ' 9 ',
' negative regulation of G1/S transition of mitotic cell cycle ': ' 12 ',
' antigen processing and presentation of exogenous antigen ': ' 17 ',
' nitric-oxide synthase biosynthetic process ': ' 5 ',
' regulation of nitric-oxide synthase biosynthetic process ': ' 5 ',
' pharyngeal system development ': ' 5 ',
' negative regulation of canonical Wnt signaling pathway ': ' 16 ',
' morphogenesis of a branching structure ': ' 19 ',
' intrinsic apoptotic signaling pathway in response to DNA damage ': ' 12 ',
' neural tube development ': ' 16 ',
' T cell differentiation in thymus ': ' 10 ',
' thymocyte aggregation ': ' 10 ',
' regulation of peptidyl-threonine phosphorylation ': ' 7 ',
' leukocyte degranulation ': ' 9 ',
' positive regulation of stress-activated MAPK cascade ': ' 14 ',
' cellular response to reactive oxygen species ': ' 14 ',
' regulation of defense response to virus by host ': ' 14 ',
' negative regulation of blood coagulation ': ' 8 ',
' negative regulation of hemostasis ': ' 8 ',
' tolerance induction ': ' 6 ',
' morphogenesis of a branching epithelium ': ' 18 ',
' mitotic G1 DNA damage checkpoint ': ' 10 ',
' negative regulation of wound healing ': ' 9 ',
' positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway ': ' 4 ',
' negative regulation of cell cycle G1/S phase transition ': ' 12 ',
' regulation of CD4-positive, alpha-beta T cell activation ': ' 7 ',
' T cell receptor signaling pathway ': ' 16 ',
' positive regulation of cellular catabolic process ': ' 25 ',
' response to gamma radiation ': ' 8 ',
' positive regulation of lipid transport ': ' 8 ',
' lymphocyte chemotaxis ': ' 8 ',
' G1 DNA damage checkpoint ': ' 10 ',
' mitotic G1/S transition checkpoint ': ' 10 ',
' in utero embryonic development ': ' 27 ',
' regulation of tyrosine phosphorylation of STAT protein ': ' 9 ',
' regulation of cartilage development ': ' 9 ',
' positive regulation of cellular protein catabolic process ': ' 17 ',
' regulation of cGMP metabolic process ': ' 6 ',
' regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway ': ' 6 ',
' positive regulation of cell killing ': ' 7 ',
' positive regulation of catabolic process ': ' 28 ',
' stem cell differentiation ': ' 22 ',
' response to organophosphorus ': ' 14 ',
' positive regulation of proteolysis involved in cellular protein catabolic process ': ' 16 ',
' immunoglobulin production ': ' 11 ',
' maintenance of protein location ': ' 11 ',
' epithelial to mesenchymal transition ': ' 12 ',
' regulation of cholesterol efflux ': ' 5 ',
' leukocyte tethering or rolling ': ' 5 ',
' negative regulation of cardiac muscle tissue development ': ' 5 ',
' leukocyte adhesion to vascular endothelial cell ': ' 5 ',
' cellular response to fluid shear stress ': ' 5 ',
' positive regulation of protein catabolic process ': ' 21 ',
' thymus development ': ' 8 ',
' positive regulation of smooth muscle cell migration ': ' 6 ',
' positive regulation of cartilage development ': ' 6 ',
' positive regulation of proteasomal ubiquitin-dependent protein catabolic process ': ' 10 ',
' negative regulation of nitric oxide biosynthetic process ': ' 4 ',
' regulation of chemokine biosynthetic process ': ' 4 ',
' positive regulation of astrocyte differentiation ': ' 4 ',
' cellular response to exogenous dsRNA ': ' 4 ',
' positive regulation of execution phase of apoptosis ': ' 4 ',
' negative regulation of nitric oxide metabolic process ': ' 4 ',
' positive regulation of thymocyte aggregation ': ' 4 ',
' positive regulation of binding ': ' 13 ',
' response to oxidative stress ': ' 28 ',
' signal transduction by p53 class mediator ': ' 16 ',
' cellular response to external stimulus ': ' 22 ',
' regulation of epithelial to mesenchymal transition ': ' 9 ',
' signal transduction involved in mitotic G1 DNA damage checkpoint ': ' 9 ',
' intracellular signal transduction involved in G1 DNA damage checkpoint ': ' 9 ',
' regulation of myotube differentiation ': ' 8 ',
' positive regulation of MAP kinase activity ': ' 18 ',
' activin receptor signaling pathway ': ' 7 ',
' cellular response to dsRNA ': ' 7 ',
' negative regulation of secretion by cell ': ' 16 ',
' regulation of vesicle-mediated transport ': ' 28 ',
' mesenchyme development ': ' 20 ',
' positive regulation of immunoglobulin production ': ' 6 ',
' substrate-dependent cell migration ': ' 6 ',
' placenta blood vessel development ': ' 6 ',
' regulation of neuroblast proliferation ': ' 6 ',
' positive regulation of cGMP metabolic process ': ' 5 ',
' endoplasmic reticulum calcium ion homeostasis ': ' 5 ',
' myeloid dendritic cell differentiation ': ' 5 ',
' positive regulation of lymphocyte apoptotic process ': ' 5 ',
' negative regulation of cell development ': ' 23 ',
' regulation of phagocytosis ': ' 9 ',
' artery development ': ' 10 ',
' positive regulation of nervous system development ': ' 30 ',
' skeletal system development ': ' 33 ',
' regulation of lymphocyte apoptotic process ': ' 8 ',
' regulation of endothelial cell migration ': ' 12 ',
' intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator ': ' 7 ',
' spleen development ': ' 7 ',
' ear development ': ' 18 ',
' homeostasis of number of cells ': ' 19 ',
' signal transduction involved in mitotic cell cycle checkpoint ': ' 9 ',
' signal transduction involved in mitotic DNA damage checkpoint ': ' 9 ',
' signal transduction involved in mitotic DNA integrity checkpoint ': ' 9 ',
' negative regulation of I-kappaB kinase/NF-kappaB signaling ': ' 8 ',
' regulation of extrinsic apoptotic signaling pathway via death domain receptors ': ' 8 ',
' positive regulation of intrinsic apoptotic signaling pathway ': ' 8 ',
' regulation of necrotic cell death ': ' 6 ',
' negative regulation of Wnt signaling pathway ': ' 17 ',
' positive regulation of T cell cytokine production ': ' 4 ',
' regulation of macrophage cytokine production ': ' 4 ',
' chemokine biosynthetic process ': ' 4 ',
' positive regulation of interleukin-8 secretion ': ' 4 ',
' regulation of T cell mediated cytotoxicity ': ' 5 ',
' regulation of cellular extravasation ': ' 5 ',
' myeloid leukocyte cytokine production ': ' 5 ',
' activated T cell proliferation ': ' 7 ',
' positive regulation of protein ubiquitination ': ' 16 ',
' ureteric bud development ': ' 11 ',
' positive regulation of interleukin-2 production ': ' 6 ',
' signal transduction involved in DNA integrity checkpoint ': ' 9 ',
' signal transduction involved in DNA damage checkpoint ': ' 9 ',
' regulation of cellular protein catabolic process ': ' 21 ',
' positive regulation of cytoplasmic transport ': ' 21 ',
' regulation of endocytosis ': ' 17 ',
' negative regulation of secretion ': ' 17 ',
' cell cycle arrest ': ' 20 ',
' negative regulation of transcription factor import into nucleus ': ' 7 ',
' negative regulation of blood pressure ': ' 7 ',
' regulation of epithelial cell migration ': ' 15 ',
' female pregnancy ': ' 17 ',
' mesonephric epithelium development ': ' 11 ',
' mesonephric tubule development ': ' 11 ',
' reproductive structure development ': ' 30 ',
' vasculogenesis ': ' 9 ',
' signal transduction involved in cell cycle checkpoint ': ' 9 ',
' lymph vessel development ': ' 5 ',
' viral life cycle ': ' 30 ',
' mitotic DNA damage checkpoint ': ' 11 ',
' negative regulation of inflammatory response ': ' 11 ',
' positive regulation of cholesterol efflux ': ' 4 ',
' macrophage cytokine production ': ' 4 ',
' hyaluronan biosynthetic process ': ' 4 ',
' response to laminar fluid shear stress ': ' 4 ',
' regulation of monocyte differentiation ': ' 4 ',
' chemokine metabolic process ': ' 4 ',
' negative regulation of necrotic cell death ': ' 4 ',
' regulation of thymocyte apoptotic process ': ' 4 ',
' negative regulation of developmental growth ': ' 10 ',
' regulation of natural killer cell mediated cytotoxicity ': ' 6 ',
' mesenchymal cell proliferation ': ' 7 ',
' reproductive system development ': ' 30 ',
' negative regulation of growth ': ' 19 ',
' protein polyubiquitination ': ' 18 ',
' regulation of stem cell differentiation ': ' 12 ',
' endothelial cell migration ': ' 14 ',
' embryonic organ morphogenesis ': ' 22 ',
' response to reactive oxygen species ': ' 18 ',
' intrinsic apoptotic signaling pathway by p53 class mediator ': ' 9 ',
' platelet-derived growth factor receptor signaling pathway ': ' 7 ',
' calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules ': ' 5 ',
' dorsal/ventral neural tube patterning ': ' 5 ',
' ovulation ': ' 5 ',
' interleukin-6 secretion ': ' 5 ',
' negative regulation of neural precursor cell proliferation ': ' 5 ',
' inner ear development ': ' 16 ',
' lipid localization ': ' 24 ',
' regulation of natural killer cell mediated immunity ': ' 6 ',
' regulation of T cell apoptotic process ': ' 6 ',
' ossification ': ' 26 ',
' JAK-STAT cascade ': ' 15 ',
' STAT cascade ': ' 15 ',
' mesonephros development ': ' 11 ',
' regulation of cell cycle G1/S phase transition ': ' 14 ',
' positive regulation of cell cycle arrest ': ' 10 ',
' positive regulation of gliogenesis ': ' 7 ',
' regulation of macrophage chemotaxis ': ' 4 ',
' response to muramyl dipeptide ': ' 4 ',
' induction of positive chemotaxis ': ' 4 ',
' regulation of mononuclear cell migration ': ' 4 ',
' mitotic cell cycle arrest ': ' 4 ',
' hepatocyte proliferation ': ' 4 ',
' epithelial cell proliferation involved in liver morphogenesis ': ' 4 ',
' positive regulation of interleukin-6 secretion ': ' 4 ',
' peptide transport ': ' 24 ',
' Notch signaling pathway ': ' 17 ',
' myeloid leukocyte mediated immunity ': ' 9 ',
' negative regulation of extrinsic apoptotic signaling pathway ': ' 10 ',
' tyrosine phosphorylation of Stat5 protein ': ' 5 ',
' positive regulation of defense response to virus by host ': ' 12 ',
' odontogenesis ': ' 12 ',
' multicellular organismal homeostasis ': ' 24 ',
' regulation of cellular response to growth factor stimulus ': ' 19 ',
' negative regulation of nucleocytoplasmic transport ': ' 9 ',
' regulation of lipid transport ': ' 10 ',
' neurotrophin TRK receptor signaling pathway ': ' 27 ',
' mitotic DNA integrity checkpoint ': ' 11 ',
' production of molecular mediator involved in inflammatory response ': ' 6 ',
' interaction with host ': ' 16 ',
' embryonic placenta development ': ' 10 ',
' positive regulation of proteasomal protein catabolic process ': ' 10 ',
' negative regulation of chemotaxis ': ' 7 ',
' positive regulation of striated muscle cell differentiation ': ' 7 ',
' regulation of B cell activation ': ' 12 ',
' appendage development ': ' 15 ',
' limb development ': ' 15 ',
' positive regulation of peptidyl-threonine phosphorylation ': ' 5 ',
' osteoblast proliferation ': ' 5 ',
' neutrophil activation ': ' 5 ',
' negative regulation of muscle contraction ': ' 5 ',
' cellular response to interleukin-6 ': ' 5 ',
' positive regulation of lymphocyte migration ': ' 5 ',
' regulation of stress-activated protein kinase signaling cascade ': ' 16 ',
' positive regulation of T cell mediated cytotoxicity ': ' 4 ',
' negative regulation of myeloid cell apoptotic process ': ' 4 ',
' glial cell apoptotic process ': ' 4 ',
' positive regulation of transforming growth factor beta production ': ' 4 ',
' mononuclear cell migration ': ' 4 ',
' negative regulation of reactive oxygen species biosynthetic process ': ' 4 ',
' digestive system development ': ' 14 ',
' immune response-activating cell surface receptor signaling pathway ': ' 24 ',
' regulation of tissue remodeling ': ' 8 ',
' neurotrophin signaling pathway ': ' 27 ',
' positive regulation of cellular component biogenesis ': ' 27 ',
' positive regulation of protein modification by small protein conjugation or removal ': ' 16 ',
' positive regulation of intracellular protein transport ': ' 19 ',
' regulation of proteolysis involved in cellular protein catabolic process ': ' 19 ',
' peptidyl-threonine phosphorylation ': ' 9 ',
' cellular response to hydrogen peroxide ': ' 9 ',
' regulation of sterol transport ': ' 6 ',
' regulation of cholesterol transport ': ' 6 ',
' regulation of activated T cell proliferation ': ' 6 ',
' mammary gland duct morphogenesis ': ' 6 ',
' negative regulation of muscle tissue development ': ' 6 ',
' regulation of lymphocyte migration ': ' 6 ',
' regulation of transforming growth factor beta receptor signaling pathway ': ' 11 ',
' regulation of cellular response to transforming growth factor beta stimulus ': ' 11 ',
' cardiac septum morphogenesis ': ' 7 ',
' positive regulation of stem cell differentiation ': ' 7 ',
' positive regulation of cell cycle process ': ' 19 ',
' positive regulation of endothelial cell migration ': ' 8 ',
' negative regulation of transferase activity ': ' 25 ',
' cardiac ventricle development ': ' 11 ',
' regulation of autophagy ': ' 16 ',
' positive regulation of interleukin-10 production ': ' 5 ',
' regulation of T cell differentiation in thymus ': ' 5 ',
' regulation of thymocyte aggregation ': ' 5 ',
' digestive tract development ': ' 13 ',
' regulation of G1/S transition of mitotic cell cycle ': ' 13 ',
' muscle system process ': ' 26 ',
' positive regulation of reproductive process ': ' 7 ',
' response to alcohol ': ' 25 ',
' T cell chemotaxis ': ' 4 ',
' positive regulation of sterol transport ': ' 4 ',
' positive regulation of cholesterol transport ': ' 4 ',
' morphogenesis of an epithelial bud ': ' 4 ',
' liver morphogenesis ': ' 4 ',
' regulation of cell morphogenesis involved in differentiation ': ' 23 ',
' response to ionizing radiation ': ' 13 ',
' developmental programmed cell death ': ' 6 ',
' regulation of lipid storage ': ' 6 ',
' neural tube patterning ': ' 6 ',
' regulation of macrophage derived foam cell differentiation ': ' 5 ',
' regulation of macrophage activation ': ' 5 ',
' negative regulation of striated muscle cell differentiation ': ' 5 ',
' regulation of protein catabolic process ': ' 26 ',
' branching morphogenesis of an epithelial tube ': ' 14 ',
' regulation of stem cell proliferation ': ' 10 ',
' regulation of muscle contraction ': ' 13 ',
' striated muscle contraction ': ' 13 ',
' positive regulation of neurogenesis ': ' 25 ',
' epithelial cell migration ': ' 17 ',
' regulation of peptide transport ': ' 20 ',
' regulation of Notch signaling pathway ': ' 8 ',
' negative regulation of protein import into nucleus ': ' 8 ',
' negative regulation of protein import ': ' 8 ',
' peptidyl-threonine modification ': ' 9 ',
' negative regulation of cell cycle ': ' 31 ',
' regulation of ossification ': ' 15 ',
' regulation of cell cycle arrest ': ' 11 ',
' face development ': ' 7 ',
' negative regulation of mitotic cell cycle ': ' 18 ',
' cellular response to fibroblast growth factor stimulus ': ' 23 ',
' T cell homeostasis ': ' 6 ',
' regulation of endothelial cell apoptotic process ': ' 6 ',
' positive regulation of myeloid leukocyte mediated immunity ': ' 4 ',
' negative regulation of platelet activation ': ' 4 ',
' negative regulation of interleukin-2 production ': ' 4 ',
' positive regulation of leukocyte degranulation ': ' 4 ',
' lymph node development ': ' 4 ',
' epithelial cell fate commitment ': ' 4 ',
' regulation of cardiac muscle cell action potential ': ' 4 ',
' stem cell proliferation ': ' 13 ',
' cell junction organization ': ' 19 ',
' positive T cell selection ': ' 5 ',
' prostate gland epithelium morphogenesis ': ' 5 ',
' cellular response to extracellular stimulus ': ' 16 ',
' actin filament organization ': ' 22 ',
' epithelium migration ': ' 17 ',
' positive regulation of tyrosine phosphorylation of STAT protein ': ' 7 ',
' digestive tract morphogenesis ': ' 7 ',
' negative regulation of neurogenesis ': ' 18 ',
' cellular response to oxygen levels ': ' 13 ',
' palate development ': ' 9 ',
' negative regulation of nervous system development ': ' 19 ',
' lymphocyte apoptotic process ': ' 8 ',
' mast cell activation involved in immune response ': ' 6 ',
' cholesterol efflux ': ' 6 ',
' mast cell degranulation ': ' 6 ',
' negative regulation of reactive oxygen species metabolic process ': ' 6 ',
' amide transport ': ' 24 ',
' placenta development ': ' 13 ',
' cardiac chamber development ': ' 13 ',
' antigen receptor-mediated signaling pathway ': ' 17 ',
' glycosaminoglycan metabolic process ': ' 14 ',
' extrinsic apoptotic signaling pathway via death domain receptors ': ' 9 ',
' regulation of fibroblast proliferation ': ' 9 ',
' positive regulation of epithelial cell migration ': ' 10 ',
' inner ear morphogenesis ': ' 10 ',
' negative regulation of intracellular protein transport ': ' 10 ',
' B cell homeostasis ': ' 5 ',
' response to ischemia ': ' 5 ',
' granulocyte activation ': ' 5 ',
' response to interleukin-6 ': ' 5 ',
' positive regulation of NIK/NF-kappaB signaling ': ' 5 ',
' response to fibroblast growth factor ': ' 23 ',
' regulated exocytosis ': ' 14 ',
' negative regulation of mitotic cell cycle phase transition ': ' 14 ',
' positive regulation of autophagy ': ' 8 ',
' negative regulation of leukocyte proliferation ': ' 8 ',
' regulation of receptor recycling ': ' 4 ',
' cytokine production involved in inflammatory response ': ' 4 ',
' activation of NF-kappaB-inducing kinase activity ': ' 4 ',
' detection of bacterium ': ' 4 ',
' thymocyte apoptotic process ': ' 4 ',
' cell proliferation involved in kidney development ': ' 4 ',
' regulation of interleukin-8 secretion ': ' 4 ',
' negative regulation of stem cell proliferation ': ' 4 ',
' cellular response to hypoxia ': ' 12 ',
' regionalization ': ' 23 ',
' T cell selection ': ' 6 ',
' positive regulation of neural precursor cell proliferation ': ' 6 ',
' somite development ': ' 9 ',
' cell-substrate adhesion ': ' 21 ',
' tissue migration ': ' 17 ',
' vasodilation ': ' 8 ',
' blood vessel endothelial cell migration ': ' 8 ',
' appendage morphogenesis ': ' 13 ',
' limb morphogenesis ': ' 13 ',
' regulation of striated muscle tissue development ': ' 10 ',
' positive regulation of B cell activation ': ' 9 ',
' T cell mediated cytotoxicity ': ' 5 ',
' positive regulation of mesenchymal cell proliferation ': ' 5 ',
' macrophage derived foam cell differentiation ': ' 5 ',
' response to ATP ': ' 5 ',
' cellular response to glucose starvation ': ' 5 ',
' prostate gland morphogenesis ': ' 5 ',
' foam cell differentiation ': ' 5 ',
' ear morphogenesis ': ' 11 ',
' mast cell mediated immunity ': ' 6 ',
' negative regulation of tumor necrosis factor production ': ' 6 ',
' positive regulation of nitric oxide biosynthetic process ': ' 6 ',
' positive regulation of nitric oxide metabolic process ': ' 6 ',
' regulation of blood pressure ': ' 14 ',
' response to ketone ': ' 14 ',
' release of cytochrome c from mitochondria ': ' 7 ',
' natural killer cell mediated cytotoxicity ': ' 7 ',
' negative regulation of muscle cell differentiation ': ' 7 ',
' striated muscle cell differentiation ': ' 18 ',
' positive regulation of cellular amide metabolic process ': ' 10 ',
' regulation of stress-activated MAPK cascade ': ' 15 ',
' osteoblast development ': ' 4 ',
' regulation of T cell cytokine production ': ' 4 ',
' parturition ': ' 4 ',
' response to muscle stretch ': ' 4 ',
' labyrinthine layer blood vessel development ': ' 4 ',
' detection of other organism ': ' 4 ',
' regulation of lymphocyte chemotaxis ': ' 4 ',
' fibroblast proliferation ': ' 9 ',
' neural precursor cell proliferation ': ' 12 ',
' cell junction assembly ': ' 17 ',
' regulation of fat cell differentiation ': ' 10 ',
' regulation of muscle organ development ': ' 10 ',
' regulation of muscle tissue development ': ' 10 ',
' ventricular septum development ': ' 7 ',
' positive regulation of carbohydrate metabolic process ': ' 8 ',
' negative regulation of protein localization to nucleus ': ' 8 ',
' cytoplasmic sequestering of protein ': ' 6 ',
' endothelial cell apoptotic process ': ' 6 ',
' negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains ': ' 5 ',
' regulation of platelet activation ': ' 5 ',
' positive regulation of glial cell differentiation ': ' 5 ',
' negative regulation of signal transduction in absence of ligand ': ' 5 ',
' negative regulation of extrinsic apoptotic signaling pathway in absence of ligand ': ' 5 ',
' aminoglycan metabolic process ': ' 14 ',
' positive regulation of cell morphogenesis involved in differentiation ': ' 13 ',
' response to purine-containing compound ': ' 13 ',
' actin filament bundle organization ': ' 11 ',
' ERBB signaling pathway ': ' 24 ',
' positive regulation of synapse assembly ': ' 7 ',
' regulation of cell-matrix adhesion ': ' 9 ',
' Rho protein signal transduction ': ' 13 ',
' regulation of chronic inflammatory response ': ' 3 ',
' immature T cell proliferation ': ' 3 ',
' positive regulation of osteoblast proliferation ': ' 3 ',
' bone mineralization involved in bone maturation ': ' 3 ',
' natural killer cell chemotaxis ': ' 3 ',
' positive regulation of odontogenesis ': ' 3 ',
' development of secondary sexual characteristics ': ' 3 ',
' eosinophil chemotaxis ': ' 3 ',
' macrophage apoptotic process ': ' 3 ',
' regulation of chemokine secretion ': ' 3 ',
' muscle tissue development ': ' 23 ',
' aorta development ': ' 6 ',
' cGMP metabolic process ': ' 6 ',
' genitalia development ': ' 6 ',
' regulation of alcohol biosynthetic process ': ' 6 ',
' negative regulation of tumor necrosis factor superfamily cytokine production ': ' 6 ',
' regulation of extrinsic apoptotic signaling pathway in absence of ligand ': ' 6 ',
' positive regulation of ion transport ': ' 17 ',
' response to protozoan ': ' 4 ',
' T cell lineage commitment ': ' 4 ',
' regulation of T-helper 1 type immune response ': ' 4 ',
' smooth muscle tissue development ': ' 4 ',
' regulation of myoblast fusion ': ' 4 ',
' positive regulation of T cell migration ': ' 4 ',
' myeloid dendritic cell activation ': ' 5 ',
' vascular endothelial growth factor production ': ' 5 ',
' cellular response to decreased oxygen levels ': ' 12 ',
' regulation of striated muscle contraction ': ' 8 ',
' proteasome-mediated ubiquitin-dependent protein catabolic process ': ' 24 ',
' natural killer cell mediated immunity ': ' 7 ',
' response to endoplasmic reticulum stress ': ' 18 ',
' nephron epithelium development ': ' 10 ',
' regulation of chondrocyte differentiation ': ' 6 ',
' endothelial cell differentiation ': ' 9 ',
' response to hydrogen peroxide ': ' 11 ',
' connective tissue development ': ' 17 ',
' regulation of myeloid leukocyte differentiation ': ' 10 ',
' regulation of blood vessel size ': ' 12 ',
' regulation of organ formation ': ' 5 ',
' face morphogenesis ': ' 5 ',
' proteasomal protein catabolic process ': ' 25 ',
' regulation of antigen processing and presentation ': ' 4 ',
' regulation of cGMP biosynthetic process ': ' 4 ',
' response to interferon-beta ': ' 4 ',
' regulation of ruffle assembly ': ' 4 ',
' endoplasmic reticulum unfolded protein response ': ' 11 ',
' mucopolysaccharide metabolic process ': ' 11 ',
' cardiac septum development ': ' 9 ',
' muscle cell differentiation ': ' 23 ',
' regulation of tube size ': ' 12 ',
' regulation of synapse assembly ': ' 8 ',
' regulation of anatomical structure size ': ' 28 ',
' second-messenger-mediated signaling ': ' 17 ',
' negative regulation of cell cycle phase transition ': ' 14 ',
' response to estrogen ': ' 16 ',
' cell fate commitment ': ' 18 ',
' embryonic pattern specification ': ' 7 ',
' regulation of cardiac muscle contraction ': ' 7 ',
' regulation of cytokine secretion involved in immune response ': ' 3 ',
' sphingosine-1-phosphate signaling pathway ': ' 3 ',
' hemidesmosome assembly ': ' 3 ',
' positive regulation of Rho protein signal transduction ': ' 3 ',
' lateral sprouting from an epithelium ': ' 3 ',
' chemokine secretion ': ' 3 ',
' positive regulation of endoplasmic reticulum unfolded protein response ': ' 3 ',
' cardiac muscle contraction ': ' 10 ',
' lipid transport ': ' 20 ',
' positive regulation of histone modification ': ' 8 ',
' signal transduction in absence of ligand ': ' 8 ',
' defense response to Gram-positive bacterium ': ' 8 ',
' renal tubule morphogenesis ': ' 8 ',
' extrinsic apoptotic signaling pathway in absence of ligand ': ' 8 ',
' negative regulation of adaptive immune response ': ' 5 ',
' positive regulation of protein acetylation ': ' 5 ',
' positive regulation of cell division ': ' 11 ',
' negative regulation of locomotion ': ' 18 ',
' regulation of smooth muscle cell migration ': ' 6 ',
' lysosome localization ': ' 6 ',
' regulation of blood vessel endothelial cell migration ': ' 6 ',
' T cell apoptotic process ': ' 6 ',
' natural killer cell differentiation ': ' 4 ',
' regulation of osteoblast proliferation ': ' 4 ',
' interleukin-8 secretion ': ' 4 ',
' cellular response to unfolded protein ': ' 11 ',
' negative regulation of intracellular transport ': ' 12 ',
' B cell differentiation ': ' 10 ',
' viral entry into host cell ': ' 10 ',
' response to unfolded protein ': ' 13 ',
' receptor metabolic process ': ' 12 ',
' regulation of mast cell activation ': ' 5 ',
' negative regulation of striated muscle tissue development ': ' 5 ',
' embryonic digestive tract development ': ' 5 ',
' labyrinthine layer development ': ' 6 ',
' protein homooligomerization ': ' 18 ',
' muscle adaptation ': ' 8 ',
' vascular process in circulatory system ': ' 13 ',
' response to insulin ': ' 27 ',
' negative regulation of cell morphogenesis involved in differentiation ': ' 10 ',
' negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway ': ' 10 ',
' chondrocyte differentiation ': ' 9 ',
' embryonic limb morphogenesis ': ' 11 ',
' embryonic appendage morphogenesis ': ' 11 ',
' nephron development ': ' 11 ',
' negative regulation of neuron differentiation ': ' 14 ',
' regulation of proteasomal protein catabolic process ': ' 14 ',
' positive regulation of chromatin modification ': ' 8 ',
' regulation of T cell tolerance induction ': ' 3 ',
' positive regulation of cellular extravasation ': ' 3 ',
' positive regulation of macrophage activation ': ' 3 ',
' positive regulation of interleukin-2 biosynthetic process ': ' 3 ',
' negative regulation of cofactor metabolic process ': ' 3 ',
' negative regulation of coenzyme metabolic process ': ' 3 ',
' regulation of necroptotic process ': ' 3 ',
' otic vesicle morphogenesis ': ' 3 ',
' interleukin-10 secretion ': ' 3 ',
' sphingolipid mediated signaling pathway ': ' 3 ',
' mesenchymal cell apoptotic process ': ' 3 ',
' inorganic cation import into cell ': ' 3 ',
' inorganic ion import into cell ': ' 3 ',
' regulation of protein polyubiquitination ': ' 3 ',
' regulation of mesenchymal cell apoptotic process ': ' 3 ',
' apoptotic mitochondrial changes ': ' 10 ',
' negative regulation of organ growth ': ' 4 ',
' cardiac epithelial to mesenchymal transition ': ' 4 ',
' renal system vasculature development ': ' 4 ',
' kidney vasculature development ': ' 4 ',
' regulation of execution phase of apoptosis ': ' 4 ',
' positive regulation of alcohol biosynthetic process ': ' 4 ',
' regulation of T cell migration ': ' 4 ',
' embryo implantation ': ' 6 ',
' positive regulation of reactive oxygen species biosynthetic process ': ' 6 ',
' muscle cell proliferation ': ' 12 ',
' cellular response to carbohydrate stimulus ': ' 11 ',
' regulation of smooth muscle cell proliferation ': ' 9 ',
' hyaluronan metabolic process ': ' 5 ',
' establishment of endothelial barrier ': ' 5 ',
' humoral immune response ': ' 15 ',
' regulation of actin filament-based process ': ' 20 ',
' anterior/posterior pattern specification ': ' 15 ',
' negative regulation of mononuclear cell proliferation ': ' 7 ',
' negative regulation of behavior ': ' 7 ',
' negative regulation of lymphocyte proliferation ': ' 7 ',
' positive regulation of stem cell proliferation ': ' 7 ',
' cell projection assembly ': ' 23 ',
' regulation of cardiac muscle tissue development ': ' 6 ',
' entry into host cell ': ' 10 ',
' entry into host ': ' 10 ',
' entry into cell of other organism involved in symbiotic interaction ': ' 10 ',
' entry into other organism involved in symbiotic interaction ': ' 10 ',
' movement in host environment ': ' 10 ',
' movement in environment of other organism involved in symbiotic interaction ': ' 10 ',
' pattern specification process ': ' 27 ',
' positive regulation of muscle cell differentiation ': ' 8 ',
' regulation of mesenchymal cell proliferation ': ' 5 ',
' negative regulation of muscle organ development ': ' 5 ',
' regulation of activin receptor signaling pathway ': ' 4 ',
' regulation of response to interferon-gamma ': ' 4 ',
' detection of external biotic stimulus ': ' 4 ',
' cholesterol transport ': ' 7 ',
' cellular biogenic amine metabolic process ': ' 14 ',
 },
 'Cellular component': {
' side of membrane ': ' 39 ',
' membrane raft ': ' 27 ',
' membrane microdomain ': ' 27 ',
' MHC protein complex ': ' 7 ',
' integral component of lumenal side of endoplasmic reticulum membrane ': ' 7 ',
' lumenal side of endoplasmic reticulum membrane ': ' 7 ',
' lumenal side of membrane ': ' 7 ',
' endosomal part ': ' 30 ',
' CD40 receptor complex ': ' 4 ',
' early endosome ': ' 23 ',
' endosome membrane ': ' 28 ',
' ER to Golgi transport vesicle membrane ': ' 8 ',
' external side of plasma membrane ': ' 21 ',
' phagocytic vesicle membrane ': ' 8 ',
' phagocytic vesicle ': ' 10 ',
' endocytic vesicle membrane ': ' 14 ',
' integral component of endoplasmic reticulum membrane ': ' 12 ',
' autophagosome ': ' 9 ',
' intrinsic component of endoplasmic reticulum membrane ': ' 12 ',
' early endosome membrane ': ' 11 ',
' endocytic vesicle ': ' 19 ',
' vesicle membrane ': ' 31 ',
' apicolateral plasma membrane ': ' 4 ',
' ER to Golgi transport vesicle ': ' 8 ',
' neuromuscular junction ': ' 7 ',
 },
 'Molecular function': {
' cytokine receptor binding ': ' 42 ',
' cytokine activity ': ' 32 ',
' CXCR chemokine receptor binding ': ' 9 ',
' chemokine activity ': ' 13 ',
' chemokine receptor binding ': ' 14 ',
' G-protein coupled receptor binding ': ' 26 ',
' cytokine receptor activity ': ' 14 ',
' tumor necrosis factor receptor binding ': ' 8 ',
' glycosaminoglycan binding ': ' 21 ',
' tumor necrosis factor receptor superfamily binding ': ' 9 ',
' peptide antigen binding ': ' 7 ',
' ubiquitin protein ligase binding ': ' 23 ',
' ubiquitin-like protein ligase binding ': ' 23 ',
' cytokine binding ': ' 11 ',
' transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding ': ' 25 ',
' transforming growth factor beta receptor binding ': ' 8 ',
' transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding ': ' 24 ',
 }
 }
},
    points = [],
      regionP,
      regionVal,
      regionI = 0,
      countryP,
      countryI,
      causeP,
      causeI,
      region,
      country,
      cause
      
      for (region in data) {
      if (data.hasOwnProperty(region)) {
      regionVal = 0;
      regionP = {
      id: 'id_' + regionI,
      name: region,
      color: Highcharts.getOptions().colors[regionI]
      };
      countryI = 0;
      for (country in data[region]) {
      if (data[region].hasOwnProperty(country)) {
      countryP = {
      id: regionP.id + '_' + countryI,
      name: country,
      parent: regionP.id
      };
      points.push(countryP);
      causeI = 0;
      for (cause in data[region][country]) {
      if (data[region][country].hasOwnProperty(cause)) {
      causeP = {
      id: countryP.id + '_' + causeI,
      name: cause,
      parent: countryP.id,
      value: Math.round(+data[region][country][cause])
      };
      regionVal += causeP.value;
      points.push(causeP);
      causeI = causeI + 1;
      }
      }
      countryI = countryI + 1;
      }
      }
      regionP.value = Math.round(regionVal / countryI);
      points.push(regionP);
      regionI = regionI + 1;
      }
      }
      Highcharts.chart('container', {
      series: [{
      type: 'treemap',
      layoutAlgorithm: 'squarified',
      allowDrillToNode: true,
      animationLimit: 1000,
      dataLabels: {
      enabled: false
      },
      levelIsConstant: false,
      levels: [{
      level: 1,
      dataLabels: {
      enabled: true
      },
      borderWidth: 3
      }],
      data: points
      }],
      subtitle: {
      text: 'Click points to drill down. Source: <a href="http://apps.who.int/gho/data/node.main.12?lang=en">WHO</a>.'
      },
      title: {
      text: 'GSEA Go-terms global view'
      }
      });
